Article citationsMore>>

S. Bhende, S. Rothenburger, D. Spangler, et al., “In Vitro Assessment of Microbial Barrier Properties of Dermabond Topical Skin Adhesive,” Surgical Infections, Vol. 3, No. 3, 2002, pp. 251-257. doi:10.1089/109629602761624216

has been cited by the following article:

• TITLE: Dermabond Protape (Prineo) for Wound Closure in Plastic Surgery

  AUTHORS: Martijn P. J. Loonen, Marc A. M. Depoorter

  KEYWORDS: Skin Mesh; Skin Adhesive; Wound Closure

  JOURNAL NAME: Modern Plastic Surgery, Vol.2 No.2, April 26, 2012

  ABSTRACT: Dermabond Protape (2-octyl-cyanoacrylate and pressure sensitive adhesive mesh; Prineo, Closure Medical Corporation) is a topical mesh and skin adhesive that forms a strong polymeric bond across opposed wound edges allowing the normal healing process to occur. No published studies have already compared the use of a topical mesh en skin adhesive in wound closure. This study evaluated the possible applications of a combined mesh-adhesive system in 100 plastic surgery operations (14 different surgical procedures) with a mean follow-up of 85.5 days. The rate of allergic reaction, infection, wound dehiscence and hypertrophic scar formation were recorded in relation to patient co-morbidities, medication and tobacco consumption. No technical restrictions were found during the Dermabond Protape application. The average time for the topical mesh and skin adhesive application was 2 minutes. The Dermabond protape was removed 7 through 10 days after the operation. Three patients (3/100 or 3%) reported an allergic reaction without increased scar formation. Hyper-inflammation in one or more wound areas with a micro-abscess were noted in 11 different patients probably due to polyglactin 910 (vicryl) sutures at their scheduled follow-up visit 1 week after their operation. Increased tissue inflammation and scar formation were found in these patients with hypertrophic scars in 1 patient (1/11 or 9.1%). One upper leg wound dehiscence was seen in a diabetes mellitus patient using corticosteroids. Two patients (2/100 or 2%) with a history of tobacco abuse showed a partial wound dehiscence after an abdominoplasty and a partial areola dehiscence after mamma reduction respectively (Table 2).